Saturday, October 31, 2026

Zoomex Secures US, Canada MSB Licenses as Crypto Exchanges Push Regulatory Compliance

Cryptocurrency exchange Zoomex has obtained Money Services Business licenses in both the United States and Canada, marking a significant compliance milestone in the crypto industry's push toward regulatory legitimization. The licensing expansion signals growing institutional acceptance of crypto trading infrastructure as exchanges seek to bridge traditional finance and digital assets.

LM Salvado
LM Salvado

April 16, 2026

Zoomex Secures US, Canada MSB Licenses as Crypto Exchanges Push Regulatory Compliance
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Zoomex has secured Money Services Business (MSB) licenses in the United States and Canada, joining a growing number of crypto exchanges pursuing regulatory approval to access mainstream financial markets.1

The dual-jurisdiction licensing represents a strategic shift in crypto exchange operations. MSB registration requires exchanges to implement anti-money laundering controls, customer identification procedures, and transaction monitoring systems that align with traditional banking standards.1

Zoomex also obtained licensing from Mantle, though specific operational details remain limited.1 The multi-jurisdictional approach reflects industry-wide recognition that regulatory compliance has become essential for institutional participation in crypto markets.

The licensing push comes as traditional financial institutions increase crypto infrastructure investments. Regulatory clarity in major markets like the US and Canada reduces operational risk for banks and asset managers considering crypto trading services.

Exchange legitimization through regulatory licensing addresses longstanding institutional concerns about counterparty risk and compliance liability. MSB status brings crypto platforms under the same supervisory framework as money transmitters and payment processors, creating familiar regulatory terrain for traditional finance players.

The timing aligns with broader institutional crypto adoption trends. Asset managers require exchanges to meet specific regulatory thresholds before directing client capital to digital asset trading platforms.

For retail investors, regulated exchange status provides additional consumer protections and oversight. MSB licensing mandates financial reporting, capital requirements, and operational transparency that unlicensed platforms often lack.

The regulatory expansion trend suggests crypto exchanges are prioritizing market access over the industry's historically libertarian stance on financial regulation. Compliance costs and operational restrictions are increasingly viewed as acceptable trade-offs for institutional capital inflows.

Traditional finance integration with crypto platforms will likely accelerate through 2026 as more exchanges complete regulatory processes in key jurisdictions. The infrastructure gap between legacy banking systems and crypto markets continues to narrow as exchanges adopt conventional financial controls.

About this analysis

This is a Via News analysis. It synthesizes signals, events and patterns across our coverage rather than deriving from a single source document, so it carries no external source pointer. Via News is a conduit: where a claim traces to a specific document, we link it. How we source

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com